ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,675, issued on April 14, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).
"Conjugate of immune-stimulating il-2 analog and preparation method thereof" was invented by Yong Ho Heo (Hwaseong-si, South Korea), Euh Lim Oh (Hwaseong-si, South Korea), Da Hyeon Park (Hwaseong-si, South Korea), Jin Young Kim (Hwaseong-si, South Korea), Jun Sub Park (Hwaseong-si, South Korea), Yu Yon Kim (Hwaseong-si, South Korea), A Ram Lee (Hwaseong-si, South Korea) and Sang Yun Kim (Hwaseong-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a long-acting conjugate of an interleukin-2 analog with altered bindi...